HIGJX
Price
$21.04
Change
+$0.16 (+0.77%)
Updated
Sep 11 closing price
Net Assets
488.31M
RMFEX
Price
$63.95
Change
+$0.34 (+0.53%)
Updated
Sep 11 closing price
Net Assets
117.47B
Interact to see
Advertisement

HIGJX vs RMFEX

HIGJX vs RMFEX Comparison Chart in %
View a ticker or compare two or three
VS
HIGJX vs. RMFEX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HIGJX is a Buy and RMFEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 117B vs. HIGJX (488M). RMFEX pays higher dividends than HIGJX: RMFEX (1.41) vs HIGJX (1.21). HIGJX was incepted earlier than RMFEX: HIGJX (18 years) vs RMFEX (24 years). HIGJX (0.72) is less costly to investors than RMFEX (0.62). HIGJX is a more actively managed with annual turnover of: 47.00 vs. RMFEX (30.00). RMFEX has a lower initial minimum investment than HIGJX: RMFEX (250) vs HIGJX (10000). RMFEX annual gain was more profitable for investors over the last year : 5.11 vs. HIGJX (-6.04). RMFEX return over 5 years is better than : 37.76 vs. HIGJX (-11.86).
HIGJXRMFEXHIGJX / RMFEX
Total Expense Ratio0.720.62116%
Annual Report Gross Expense Ratio0.720.62116%
Fund Existence18 years24 years-
Gain YTD10.2878.776117%
Front LoadN/AN/A-
Min. Initial Investment100002504,000%
Min. Initial Investment IRAN/AN/A-
Net Assets488M117B0%
Annual Yield % from dividends1.211.4186%
Returns for 1 year-6.045.11-118%
Returns for 3 years2.1336.716%
Returns for 5 years-11.8637.76-31%
Returns for 10 years31.14102.4430%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOYU4.700.16
+3.52%
DouYu International Holdings Limited
CCTG0.610.01
+2.23%
CCSC Technology International Holdings Limited
QTWO60.890.56
+0.93%
Q2 Holdings
GEHC63.93-0.31
-0.48%
GE HealthCare Technologies
ACRS5.32-0.18
-3.36%
Aclaris Therapeutics